Adverse events Defined as leading to discontinuation of study medication; or for studies with standard care control, defined by study authors as "serious adverse events" · adults with acute respiratory distress syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fitness to return to work at 12 months · adults with acute respiratory distress syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Severe nausea 48 hours · Pregnant women with hyperemesis gravidarum
Corticosteroids may leads to higher severe nausea 48 hours compared with promethazine (low certainty).
1 finding from 1 review
Severe nausea 17th day · Pregnant women with hyperemesis gravidarum
It is very uncertain whether corticosteroids changes severe nausea 17th day compared with promethazine (very low certainty).
1 finding from 1 review
Vomiting · Pregnant women with hyperemesis gravidarum
It is very uncertain whether corticosteroids changes episodes of vomiting 48 hours compared with promethazine (very low certainty).
2 findings from 1 review
Intervention side effects: drowsiness 48hrs and 3‐10 days · Pregnant women with hyperemesis gravidarum
Corticosteroids showed no clear difference in intervention side effects: drowsiness 48hrs and 3‐10 days compared with promethazine (low certainty).
1 finding from 1 review
Perinatal mortality · Pregnant women with hyperemesis gravidarum
Corticosteroids showed no clear difference in stillbirth and neonatal death compared with promethazine (low certainty).
1 finding from 1 review
Preterm birth · Pregnant women with hyperemesis gravidarum
Corticosteroids showed no clear difference in preterm birth compared with promethazine (low certainty).
1 finding from 1 review
Duration of hospital admission (days) · Pregnant women with hyperemesis gravidarum
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of hospital stay · Pregnant women with hyperemesis gravidarum
1 finding from 1 review
Pregnancy complications · Pregnant women with hyperemesis gravidarum
It is very uncertain whether corticosteroids changes pregnancy complications compared with placebo (very low certainty).
1 finding from 1 review
Spontaneous abortion · Pregnant women with hyperemesis gravidarum
It is very uncertain whether corticosteroids changes spontaneous abortion compared with placebo (very low certainty).
1 finding from 1 review
Perinatal mortality · Pregnant women with hyperemesis gravidarum
It is very uncertain whether corticosteroids changes stillbirth and neonatal death compared with placebo (very low certainty).
1 finding from 1 review
Congenital abnormalities · Pregnant women with hyperemesis gravidarum
It is very uncertain whether corticosteroids changes congenital abnormalities compared with placebo (very low certainty).
1 finding from 1 review
Side effects · Pregnant women with hyperemesis gravidarum
It is very uncertain whether corticosteroids changes intervention side effects compared with placebo (very low certainty).
1 finding from 1 review
Preterm birth · Pregnant women with hyperemesis gravidarum
It is very uncertain whether corticosteroids changes preterm birth compared with placebo (very low certainty).
1 finding from 1 review
Severity, reduction or cessation in nausea/vomiting 2. Number of episodes of emesis 3. Quality of life outcomes · Pregnant women with hyperemesis gravidarum
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death ‐ at 180 days after ICU admission, in total population randomised · critically ill patients
Corticosteroids showed no clear difference in death ‐ death at 180 days in total population randomised compared with placebo compared (high certainty).
1 finding from 1 review
Serious adverse events (dichotomous data) ‐ shock · critically ill patients
Corticosteroids showed no clear difference in serious adverse events (dichotomous data) ‐ shock compared with placebo compared (high certainty).
1 finding from 1 review
Serious adverse events (dichotomous data) ‐ serious infection · critically ill patients
Corticosteroids showed no clear difference in serious adverse events (dichotomous data) ‐ serious infection compared with placebo compared (high certainty).
1 finding from 1 review